1,721,131 research outputs found
Meeting of the Strategic Advisory Group of Experts on immunization, April 2015: conclusions and recommendations
No full textThe Strategic Advisory Group of Experts (SAGE) on immunization met on 14–16 April 2015 in Geneva, Switzerland. This report summarizes the discussions, conclusions and recommendations
Meeting of the Strategic Advisory Group of Experts on immunization, October 2014 - conclusions and recommendations
No full textThe Strategic Advisory Group of Experts (SAGE) on immunization met on 21–23 October 2014 in Geneva, Switzerland. This report summarizes the discussions, conclusions and recommendations
Meeting of the Strategic Advisory Group of Experts on immunization, October 2015 - conclusions and recommendations
No full textThe Strategic Advisory Group of Experts on immunization (SAGE)1 met on 20–22 October 2015. This report summarizes the discussions, conclusions and recommendations.http://www.who.int/wer/2015/wer9050.pdfVoR - Version of Recor
Meeting of the Strategic Advisory Group of Experts on Immunization, October 2018 - Conclusions and Recommendations
No full textThe Strategic Advisory Group of Experts (SAGE) on Immunization met on 23–25 October 2018. This report summarizes the discussions, conclusions and recommendations of the Group
Meeting of the Strategic Advisory Group of Experts on immunization, October 2017 – conclusions and recommendations
No full textThe Strategic Advisory Group of Experts (SAGE) on Immunization met on 17–19 October 2017. This report summarizes the discussions, conclusions andrecommendations
A matrix of the determinants of vaccine hesitancy in India adapted from the Matrix of Hesitancy Determinants by the Strategic Advisory Group of Experts on immunization (SAGE).
No full textA matrix of the determinants of vaccine hesitancy in India adapted from the Matrix of Hesitancy Determinants by the Strategic Advisory Group of Experts on immunization (SAGE).</p
Meeting of the Strategic Group of Experts on immunization, April 2017 - conclusions and recommendations
No full textThe Strategic Advisory Group of Experts (SAGE) on Immunization—Past, Present and Future
No full textBackground/Objectives: In November 1999, WHO established the Strategic Advisory Group of Experts (SAGE) on Immunization as a multidisciplinary group of experts to provide high-level recommendations on vaccines and immunization. Methods: This review provides an overview of SAGE’s work in the past 25 years. It further outlines the processes and methods currently used by SAGE and highlights some of its major achievements. Results: SAGE’s global policies have driven action toward eradication, elimination and disease control and addressed the optimization of vaccination and immunization. In total, 27 major policy positions on vaccines/vaccine-preventable diseases have guided global public health. During times of epidemics and pandemics, interim recommendations issued by SAGE have responded iteratively in real-time to provide evidence-driven response policies. SAGE is an adaptive advisory group that has modified its procedures and working approaches to meet the evolving challenges in public health and stay up-to-date with evolving scientific and guideline development standards. Conclusions: Over the last quarter century, SAGE has significantly contributed to shaping the immunization landscape. It has achieved and maintained a high level of integrity and credibility. The advisory group continues to be an authority in global public health, and its recommendations have profound implications for the health of individuals and populations across the globe
Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine.
Get PDFThe Strategic Advisory Group of Experts (SAGE) on Immunization advises WHO on global policies for vaccines. In April, 2016, SAGE issued recommendations on the use of the first licenced dengue vaccine, CYD-TDV. In November, 2017, a retrospective analysis of clinical trial data, stratifying participants according to their dengue serostatus before the first vaccine dose, showed that although in high seroprevalence settings the vaccine provides overall population benefit, there was an excess risk of severe dengue in seronegative vaccinees. SAGE's working group on dengue vaccines met to discuss the new data and mainly considered two vaccination strategies: vaccination of populations with dengue seroprevalence rates above 80% or screening of individuals before vaccination, and vaccinating only seropositive individuals. We report on the deliberations that informed the recommendation of the pre-vaccination screening strategy, in April, 2018. Important research and implementation questions remain for CYD-TDV, including the development of a highly sensitive and specific rapid diagnostic test to determine serostatus, simplified immunisation schedules, and assessment of the need for booster doses
Salient issues on the global health agenda: how science/policy boundary‐work builds confidence in global governance. An in‐depth study of UNESCO's International Bioethics Committee and the WHO's Strategic Advisory Group of Experts on Immunization
Get PDFThis study examines the science/policy interactions in global health science and
technology governance. It focuses on the institutional design of organizations that
sit at the interface of science and policy, conceptualizing them as Boundary
Organizations (BOs). The analysis considers how the institutional design of BOs
affect boundary-work. The study examines two case studies, UNESCO’s
International Bioethics Committee and the WHO’s Strategic Advisory Group of
Experts on Immunization. The study examines the ways in which boundary-work is
carried out and finds that the concept of a BO demonstrates an institutionalization of
science/policy interactions and the analysis of these two cases show that there are
different ways that boundary-work is practiced as a function of the design of BOs
- …
